Impact of fructose diet and renal failure on the function of pancreatic islets

Pancreas

Volumn 43, Issue 5, 2014, Pages 801-808

  Pokrywczynska, Marta ^a   Flisinski, Mariusz ^a   Jundzill, Arkadiusz ^a   Krzyzanowska, Sandra ^a   Brymora, Andrzej ^b   Deptula, Aleksander ^c   Bodnar, Magdalena ^c   Kloskowski, Tomasz ^a   Stefanska, Anna ^a   Marszalek, Andrzej ^c,d   Manitius, Jacek ^a   Drewa, Tomasz ^a,e  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Department of Dialysis New Hospital in wiecie   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e Nicolaus Copernicus Hospital   (Poland)

Author keywords

Chronic kidney disease; Fructose; Metabolic syndrome; Pancreatic islets

Indexed keywords

C PEPTIDE; FRUCTOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; CREATININE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DIET; HOMEOSTASIS; INSULIN RESISTANCE; KIDNEY FAILURE; MALE; METABOLIC SYNDROME X; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET; PRIORITY JOURNAL; RAT; UNINEPHRECTOMY; UREA NITROGEN BLOOD LEVEL; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; BODY WEIGHT; CARBOHYDRATE DIET; CHRONIC KIDNEY FAILURE; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHARMACOLOGY; PHYSIOLOGY; SECRETION (PROCESS); WISTAR RAT;

ANIMALS; BODY WEIGHT; C-PEPTIDE; CREATININE; DIETARY CARBOHYDRATES; FRUCTOSE; GLUCOSE; HYPOGLYCEMIC AGENTS; IN VITRO TECHNIQUES; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; KIDNEY FAILURE, CHRONIC; MALE; RATS, WISTAR;

EID: 84902532960     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000111     Document Type: Article

References (28)

1. Hanson RL, Imperatore G, Bennett PH, et al. Components of the ''metabolic syndrome'' and incidence of type 2 diabetes. Diabetes. 2002;51:3120-3127.
2. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250. (Pubitemid 39202340)
3. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-174.
4. Alberti KG, Zimmet P, Shaw J. The metabolic syndromeVa new worldwide definition. Lancet. 2005; 366:1059-1062. (Pubitemid 41338752)
5. Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428. (Pubitemid 40523737)
7. Glinsmann WH, Bowman BA. The public health significance of dietary fructose. Am J Clin Nutr. 1993;58:820-823.
8. Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: A review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009;332:145-159.
9. Maiztegui B, Borelli MI, Raschia MA, et al. Islet adaptive changes to fructose-induced insulin resistance: Beta-cell mass, glucokinase, glucose metabolism, and insulin secretion. J Endocrinol. 2009; 200:139-149.
10. Gersch MS, MuW, Cirillo P, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol. 2007;293:F1256YF1261.
11. Sánchez-Lozada LG, Tapia E, Jiménez A, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2007;292:F423YF429.
12. Nakayama T, Kosugi T, Gersch M, et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol. 2010; 298:F712YF720.
13. Avram MM. High prevalence of pancreatic disease in chronic renal failure. Nephron. 1977;18:68-71. (Pubitemid 8055128)
14. de Koning EJ, Fleming KA, Gray DW, et al. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment. J Pathol. 1995;175:253-258.
15. Cao P, Marek P, Noor H, et al. Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett. 2013;587:1106-1118.
16. Ricordi C, Rastellini C. Methods in pancreatic islets separation. In: Ricordi C, ed. Methods in Cell Transplantation. Austin, TX: R.G. Landes; 1995:433-438.
17. Curry DL. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas. 1989;4:2-9. (Pubitemid 19152464)
18. Elliott SS, Keim NL, Stern JS, et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:911-922. (Pubitemid 35244659)
19. Steil GM, Trivedi N, Jonas JC, et al. Adaptation of beta-cell mass to substrate oversupply: Enhanced function with normal gene expression. Am J Physiol Endocrinol Metab. 2001;280:E788YE796.
20. Jetton TL, Lausier J, LaRock K, et al. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: Roles of Akt kinase. Diabetes. 2005;54:2294-2304. (Pubitemid 41134255)
21. Liu YQ, Jetton TL, Leahy JL. Beta-cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem. 2002;277:39163-39168. (Pubitemid 35190884)
22. Chen C, Hosokawa H, Bumbalo LM, et al. Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in A-cells. J Clin Invest. 1994;94:399-404.
23. Pokrywczynska M, Krzyzanowska S, Jundzill A, et al. Differentiation of stem cells into insulin-producing cells: Current status and challenges. Arch Immunol Ther Exp (Warsz). 2013;61:149-158.
24. Anello M, Lupi R, Spampinato D, et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia. 2005;48:282-289. (Pubitemid 40543300)
25. Ehehalt F, Knoch K, Erdmann K, et al. Impaired insulin turnover in islets from type 2 diabetic patients. Islets. 2010;2:30-36.
26. Marchetti P, Del Guerra S, Marselli L, et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab. 2004;89:5535-5541. (Pubitemid 39518437)
27. Del Guerra S, Lupi R, Marselli L, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes. 2005;54:727-735. (Pubitemid 40322075)
28. Sui Y, Zhao HL, Ma RC, et al. Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci. 2007;64:3119-3128. (Pubitemid 351152242)